Can Beazley PLC Oust Aviva plc, Prudential plc And RSA Insurance Group plc From Your Portfolio?

Could Beazley PLC’s (LON: BEZ) strong results make it a better buy than Aviva plc (LON: AV), Prudential plc (LON: PRU) and RSA Insurance Group plc (LON: RSA)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE100It’s been a rather disappointing year for investors in Beazley (LSE: BEZ) with shares in the insurer falling by 3% year-to-date. That doesn’t compare favourably to the FTSE 100’s performance, with the wider index up just under 1% over the same time period. However, as this week’s update from Beazley showed, the company is making encouraging progress, with premium growth and international growth both being significantly stronger than expected. Together, they enabled the company to beat expectations for the first half of the year, with management expecting the second half to be a similar story.

So, with a potential tailwind, is Beazley a better buy for your portfolio than Aviva (LSE: AV) (NYSE: AV.US), Prudential (LSE: PRU) and RSA (LSE: RSA)?

Attractive Valuations

Trading on a price to earnings (P/E) ratio of just 11.1, Beazley offers great value for money at current levels. Indeed, it compares favourably to its larger sector peers on this front, with only Aviva trading on a lower P/E of 10.6. Prudential and RSA, meanwhile, have P/Es of 14.3 and 11.8 respectively which, although higher than their two sector peers, are still attractive when compared to the FTSE 100’s P/E of 13.9.

Top Yields

As ever, insurers provide income-seeking investors with sound prospects. On this front, Beazley outperforms its rivals, since it offers a yield of 4%, while Aviva, Prudential and RSA are slightly behind on 3.4%, 2.6% and 2.5% respectively. However, where Beazley disappoints is with regard to next year’s dividend forecasts, with the company set to see dividends per share fall by 6.7% next year, as the company’s bottom-line is also set to tumble by 23%.

This is disappointing and shows that, while Beazley’s current yield is higher than that of its peers, their dividend per share growth over the next couple of years will narrow the gap and, in Aviva’s case, overtake Beazley’s yield.

Looking Ahead

As mentioned, Beazley’s update for the first half of the year was ahead of market expectations. However, the company is still forecast to report a decline in earnings over the next two years. Unlike Beazley, Aviva, Prudential and RSA are all in the midst of bottom-line growth periods and, as a result, their share prices could be more buoyant going forward.

That’s not to say that Beazley doesn’t have potential. It offers investors good value, a strong yield and longer term growth prospects. For now, though, it is still outmatched by its three larger rivals.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares in Aviva and RSA. The Motley Fool has no position in any of the shares mentioned.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

This 1 simple investing move accelerated Warren Buffett’s wealth creation

Warren Buffett has used this easy to understand investing technique for decades -- and it has made him billions. Our…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Down 6% in 2 weeks, the Lloyds share price is in reverse

After hitting a one-year high on 8 April, the Lloyds share price has suddenly reversed course. But as a long-term…

Read more »

Investing Articles

£3,000 in savings? Here’s how I’d use that to start earning a monthly passive income

Our writer digs into the details of how spending a few thousand pounds on dividend shares now could help him…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »